AAV-ShH10 Serotype
Simian-human hybrid AAV combining rhesus and human capsid elements for broad tissue tropism with lower pre-existing immunity in human populations.
| Tropism | Liver, CNS, muscle (broad tropism) |
|---|
Characteristics
Hybrid capsid from simian and human AAV sources. Lower pre-existing neutralizing antibodies versus AAV2. Broad tissue tropism across liver, CNS, and muscle. Enhanced transduction efficiency. Favorable immune profile.
Applications
Hemophilia gene therapy. CNS disease applications. Multi-tissue gene therapy requiring broad tropism. Clinical applications in antibody-positive patients.
Sequence1 bp
Sign in to view the full sequence.
Sign inReferences
- 1.Choudhury et al. (2016). Viral vectors for therapy of neurologic diseases. Mol Ther — Choudhury 2016 ShH10
